Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Guerbet clinical trials
The registry lists 42 studies whose lead sponsor is Guerbet. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 7, 2026.
Keep track of what changes. Save the Guerbet studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Guerbet.
- Guerbet42 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 42 of 42.
- Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular DiseaseRecruitingNCT07348640Phase 3
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingNCT04373564Phase 4
- Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and ChildrenCompletedNCT06010173Phase 3
- Performance of Elucirem in DSC-MRI Perfusion of Brain GliomasCompletedNCT06057168Phase 3
- Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of AgeCompletedNCT05590884Phase 2
- Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)CompletedNCT03986138Phase 3
- A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization ProceduresCompletedNCT02625389Phase 4
- Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)CompletedNCT03996447Phase 3
- Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-upStatus unknownNCT05316077
- Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT ExaminationStatus unknownNCT05537779
- Cardiac Safety Evaluation of P03277CompletedNCT03657264Phase 1
- Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRICompletedNCT03749252Phase 2
- Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC DiagnosisCompletedNCT02973516Phase 2
- P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)CompletedNCT02633501Phase 2
- Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy VolunteersCompletedNCT04906005Phase 1
- Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain LesionsCompletedNCT03603106Phase 1/2
- Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal FunctionCompletedNCT03657784Phase 1
- DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCCTerminatedNCT01806740Phase 4
- Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary AtherosclerosisCompletedNCT01254552Phase 4
- Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) LesionsCompletedNCT01211873Phase 3
- Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed TomographyTerminatedNCT00793182Phase 4
- Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem AdministrationCompletedNCT01467271
- Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK InjectionWithdrawnNCT00811863
- Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric PatientsCompletedNCT01092754Phase 4
- Hepatic Xenetix-CT PerfusionCompletedNCT01639703Phase 4
- Post-marketing Surveillance Study for Evaluation of Dotarem SafetyCompletedNCT03048006
- Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance MammographyCompletedNCT03041298
- DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 YearsCompletedNCT02411201Phase 4
- Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)CompletedNCT01523873
- Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain TumorsCompletedNCT02034708Phase 4
- Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)CompletedNCT01012674Phase 3
- Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)CompletedNCT01010932Phase 3
- Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)TerminatedNCT00980681Phase 3
- Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)TerminatedNCT00845702Phase 3
- Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT AngiographyCompletedNCT01255722Phase 4
- Safety and Dialysability of Dotarem® in Dialysed PatientsCompletedNCT01449266Phase 1
- Renal Safety Evaluation After Dotarem®-Enhanced MRICompletedNCT00650845Phase 4
- A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric IndicationsCompletedNCT00347022Phase 4
- Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial DiseaseCompletedNCT01026389Phase 4
- DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial DiseasesCompletedNCT00955617Phase 4
- A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) AngiographyCompletedNCT00447889Phase 4
- A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal AngiographyCompletedNCT00382317Phase 4